Robert Spiera Selected Research

Wegener Granulomatosis (Wegener's Granulomatosis)

05/2008	Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.
12/2007	The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event.
11/2007	Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.
07/2007	ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
05/2007	Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations.
05/2006	Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
07/2005	Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

7	Wegener Granulomatosis (Wegener's Granulomatosis) 05/2008 - 07/2005
1	Systemic Scleroderma (Systemic Sclerosis) 06/2008
1	Thrombophilia 12/2007

2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2007 - 07/2007
2	TNFR-Fc fusion protein (etanercept)FDA Link 05/2006 - 07/2005
1	Collagen Type I (Type I Collagen)IBA 06/2008
1	GlucocorticoidsIBA 05/2008
1	Anticardiolipin AntibodiesIBA 12/2007
1	AntibodiesIBA 05/2007